Literature DB >> 12231102

Estimation of glomerular filtration rate to prevent life-threatening hyperkalemia due to combined therapy with spironolactone and angiotensin-converting enzyme inhibition or angiotensin receptor blockade.

Daniel A Blaustein1, Krishnan Babu, Arpitha Reddy, Michael H Schwenk, Morrell M Avram.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12231102     DOI： 10.1016/s0002-9149(02)02580-8

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  4 in total

1.  Interaction of spironolactone with ACE inhibitors or angiotensin receptor blockers: analysis of 44 cases.

Authors:  Eike Wrenger; Regina Müller; Michael Moesenthin; Tobias Welte; Jürgen C Frölich; Klaus H Neumann
Journal:  BMJ       Date:  2003-07-19

Review 2.  Pharmacokinetics and pharmacodynamics of mineralocorticoid blocking agents and their effects on potassium homeostasis.

Authors:  Domenic A Sica
Journal:  Heart Fail Rev       Date:  2005-01       Impact factor: 4.214

Review 3.  The risks and benefits of aldosterone antagonists.

Authors:  Domenic A Sica
Journal:  Curr Heart Fail Rep       Date:  2005-08

Review 4.  Well tolerated spironolactone-related hyponatremia.

Authors:  Joel Handler
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-04       Impact factor: 3.738
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.